Allied CorpOTCQB:ALID
- LAST PRICE0.0505
- TODAY'S CHANGE (%)0.0005 (0.9700%)
- Bid / Lots0.0405/ 100
- Ask / Lots0.0970/ 100
- Open / Previous Close0.0549 / 0.0500
- Day Range
- 52 Week Range
- Volume10,451
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALID |
|---|---|---|
| 11:36 ET | 400 | 0.051 |
| 12:53 ET | 600 | 0.050485 |
| 12:55 ET | 9451 | 0.050485 |
Industry Peers
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Allied Corp | 5.5M | -0.7x | --- |
Sentient Brands Holdings Inc | 5.4M | -5.1x | --- |
SYBLEU Inc | 5.5M | -1.9x | --- |
Resonate Blends Inc | 590.4K | -0.3x | --- |
CanaQuest Medical Corp | 802.9K | -0.8x | --- |
Kaya Holdings Inc | 709.5K | 0.3x | -17.15% |
Company Information
Allied Corp. is a Canadian cannabis supplier with its production center in Colombia. It is focused on the development of Colombian produced medicinal cannabis for patients with conditions potentially suitable for treatment. Such conditions include anxiety, insomnia, anorexia, chronic pain, epilepsy, chemotherapy-induced nausea and vomiting, post-traumatic stress disorder, Parkinson's disease, Tourette's syndrome, irritable bowel syndrome and spasticity associated with multiple sclerosis and spinal cord injury. Its core hemp derived cannabidiol (CBD) brands are Tactical Relief Brand, Equilibrium Bio and MaXXa. Liberty, Tactical Relief brand's flagship product, is a hemp derived CBD tincture for sale in the United States. Equilibrium Bio brand is primarily focused on hydration and recovery areas. MaXXa brand develops natural CBD infused cosmetics and beauty products. Its subsidiaries include AM Biosciences, Allied US Products LLC, Tactical Relief LLC, Baleno Ltd. and Allied Colombia.
Contact Information
- Headquarters
- SUITE 200-460 DOYLE AVEKELOWNA, BC, Canada V1Y OC2
- Phone
- 778-388-5258
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Calum Hughes
- Chief Operating Officer, Director
- Paul Bullock
- Vice President of Pharmaceuticals and Director
- Jim Smeeding
- Vice President - Corporate Development
- Santiago Ribero
- Chief Business Development Officer
- Michael Moses
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | --- |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | --- |
Allied Corp does not pay a dividend. | |
Beta | --- |
EPS | --- |
Book Value | --- |
P/E Ratio | -0.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
